Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk of developing breast cancer compared with women in the general population, according to a study published in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
What could some day be the first blood test for the early detection of breast cancer was shown in preliminary studies to identify successfully the presence of breast cancer cells from serum biomarkers, say the Houston Methodist Research Institute scientists who are developing the technology.
Two studies, published in The Lancet and The Lancet Oncology, show that for some women undergoing surgery for early breast cancer, targeted radiotherapy delivered during surgery could offer a viable alternative to current procedures, which require women to attend daily radiotherapy sessions for weeks after surgery.
The National Cancer Registry Ireland outlines the incidence and trends in non-melanoma skin cancer, including male-to-female ratios and differing rates in terms of social deprivation. Non-melanoma skin cancer Case numbers and histological types Between 1994 and 2011, an average of 6,899 cases of invasive skin cancer were diagnosed per year in Ireland. Malignant melanoma accounted […]
Fifty five per cent of Irish breast cancer survivors did not feel that adequate support group services were available to them, according to a new study looking at breast cancer survivors’ needs, published in the Irish Medical Journal. Currently there is no published data on survivor care in Irish patients and knowledge of their specific […]
Ireland’s spending on cancer care per citizen in 2009 was the 15th lowest in the EU, the first ever study to evaluate the economic cost of cancer across the 27 countries of the EU has revealed.
People who have a first- through third-degree relative diagnosed with papillary thyroid cancer (PTC) have an increased risk of developing it themselves, according to a study by Gretchen M Oakley MD of the University of Utah School of Medicine, Salt Lake City, and colleagues, published in JAMA Otolaryngology-Head & Neck Surgery. To define the family […]
Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of — and ultimately left no detectable trace of — brain tumour cells taken from adult human patients.
The National Cancer Registry Ireland provides an overview of national incidence rates in Hodgkin’s lymphoma.
Laparoscopic surgery in a dedicated, minimally-invasive unit with verifiable low conversion rates is feasible and in the researchers’ experience, is associated with a long term survival advantage for colon cancer, according to a study published in the Irish Medical Journal.